Donahue BA, Yin S., Taylor J.-S, Reines D., and Hanawalt PC (1994). Transcript cleavage by RNA polymerase II arrested by a cyclobutane pyrimidine dimer on the DNA template. Proc. Natl. Acad. Sci. USA91: 8502-8506.
2.
Dumaz N., Drougard C., Sarasin A., and Daya-Grosjean L. (1993). Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. USA90: 10529-10533.
3.
Evans MK, Taffe BG, Harris CC, and Bohr VA (1993). DNA strand bias in the repair of the p53 gene in normal and xeroderma pigmentosum group C fibroblasts. Cancer Res. 53: 5377-5381.
4.
Ford JM, Lommel L., and Hanawalt PC (1994). Preferential repair of UV-induced DNA damage in the transcribed strand of the human p53 gene. Molec. Carcinogen . 10: 105-109.
5.
Hanawalt PC (1993). 'Close-fitting sleeves'-Recognition of structural defects in duplex DNA. Mut. Res. 289: 7-15.
6.
Hanawalt PC (1994). Evolution of concepts in DNA repair. Environ. Molec. Mutagen. 23(suppl. 24): 78-85.
7.
Hanawalt PC, Donahue BA, and Sweder KS (1994). Repair and transcription: Collision or collusion? Curr. Biol. 4(6): 518-521.
8.
Hanawalt PC and Mellon I. (1993). DNA repair: Stranded in an active gene. Curr. Biol. 3(1): 67-69.
9.
Mellon I., Spivak G., and Hanawalt PC (1987). Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell51: 241-249.
10.
Selby CP and Sancar A. (1993). Molecular mechanism of transcription-repair coupling . Science260: 53-58.
11.
Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, de Fazio A., Watts CK, Musgrove EA, and Sutherland RL (1993). Expression and amplification of cyclin genes in human breast cancer. Oncogene8: 2127-2133.
12.
Hoffmann I., Clarke PR, Marcote MJ, Karsenti E., and Draetta G. (1993). Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis . EMBO J. 12: 53-63.
13.
Kamb A., Gruis NA, Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian SV, Stockert E., Day RS 3rd, Johnson BE, Skolnick MH (1994). A cell cycle regulator potentially involved in genesis of many tumor types . Science264: 436-440.
14.
Marcote MJ, Pagano M., and Draetta G. (1992). cdc2 protein kinase: structure-function relationships . Regulation of the Eukaryotic Cell Cycle. Ciba Foundation Symposium. Wiley, Chichester , pp. 30-49.
15.
Serrano M., Hannon GJ, and Beach D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (London)366: 704-707.
16.
Sherr CJ (1993). Mammalian G1 cyclins. Cell73: 1059-1065.
17.
Sherr CJ (1994). The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Cell. Biol. 4: 15-18.
18.
Xiong Y., Hannon GJ, Zhang H., Casso D., Kobayashi R., and Beach D. (1993). p21 is a universal inhibitor of cyclin kinases . Nature (London) 366: 701-704.
19.
Gerschenson LE and Rotello RJ (1992). Apoptosis: A different type of cell death. FASEB J. 6: 2450-2455.
20.
Gerschenson LE , Rotello RJ, Lieberman RC, and Sze C-I. (1994). Apoptosis: Definition, roles and regulation. In: The cell cycle , VW Hu (ed). Plenum Press, New York, pp. 291-299.
21.
Lynch M., Nawaz S., and Gerschenson LE (1986). Evidence for soluble factors regulating cell death and cell proliferation in primary cultures of rabbit endometrial cells grown on collagen. Proc. Natl. Acad. Sci. USA83: 4785-4788.
22.
Rotello RJ, Lieberman RC, Lepoff RB, and Gerschenson LE (1991). Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU486. Am. J. Pathol. 140: 449-456.
23.
Rotello RJ, Lieberman RC, Purchio AF, and Gerschenson LE (1991). Coordinated regulation of apoptosis and cell proliferation by TGF-β1 in cultured cells. Proc. Natl. Acad. Sci. USA88: 3412-3415.
24.
Sze C-I. , Sun W., Lieberman R., Purchio AF, and Gerschenson LE (1993). Progesterone regulates apoptosis, TGF-β1 immunostain pattern and TGF-β1 mRNA content in rabbit uterine epithelium. FASEB J. 7: A137.
25.
Smeyne RJ, Schilling K., Robertson L., Luk D., Oberdick J., Curran T., and Morgan JI (1992).fos-lacZ transgenic mice: Mapping sites of gene induction in the central nervous system. Neuron8: 13-23.
26.
Smeyne RJ, Vendrell M., Hayward M., Baker SJ, Miao GG, Schilling K., Robertson L., Curran T., and Morgan JI (1993). Fos: Continuous c-fos expression precedes programmed cell death in vivo. Nature (London)363: 166-169.
27.
Denning MF, Dlugosz AA, Howett MK, and Yuspa SH (1993). Expression of an oncogenic ras-Ha gene in murine keratinocytes induces tyrosine phosphorylation and reduced activity of protein kinase C δ. J. Biol. Chem. 268: 26079-26081.
28.
Dlugosz AA and Yuspa SH (1993). Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C. J. Cell Biol. 120: 217-225.
29.
Dlugosz AA and Yuspa SH (1994). Protein kinase C regulates keratinocyte transglutaminase (TGK) gene expression in cultured primary mouse epidermal keratinocytes induced to terminally differentiate by calcium. J. Invest. Dermatol . 102: 409-414.
30.
Strickland JE , Dlugosz AA, Hennings H., and Yuspa SH (1993). Inhibition of tumor formation from grafted murine papilloma cells by treatment of grafts with staurosporine, an inducer of squamous differentiation. Carcinogenesis14: 205-209.
31.
Yuspa SH, Kilkenny AE, Steinert PM, and Roop DR (1989). Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J. Cell Biol. 109: 1207-1217.
32.
Afshari CA, Bivins HM, and Barrett JC (1994). Utilization of a fos-lacZ plasmid to investigate the activation of c-fos during cellular senescence and okadaic acid-induced apoptosis. J. Gerontol. (in press).
33.
Barrett JC and Preston G. (1994). Apoptosis and cellular senescence: Forms of irreversible growth arrest. In: Apoptosis II: The Molecular Basis of Apoptosis in Disease, LD Tomei and FD Cope (eds). Cold Spring Harbor Laboratory, New York, pp. 253-281.
34.
Preston GA, Lang J., Maronpot R., and Barrett JC (1994). Regulation of apoptosis during neoplastic progression: Enhanced susceptibility after loss of senescence gene and decreased susceptibility after loss of a tumor susceptibility gene. Cancer Res. 54: 4214-4223.
35.
Barillari G. , Buonaguro L., Fiorelli V., Hoffman J., Michaels F., Gallo RC, and Ensoli B. (1992). Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression . J. Immunol. 149: 3727-3734.
36.
Barillari G. , Gendelman R., Gallo RC, and Ensoli B. (1993). The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells induces adhesion of the same cell types by using integrin receptors recognizing RGF amino acid sequence. Proc. Natl. Acad. Sci. USA90: 7941-7945.
37.
Ensoli B., Barillari G., Salahuddin SZ, Gallo RC, and Wong-Staal F. (1990). Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (London)345: 84-86.
38.
Ensoli B., Nakamura S., Salahuddin SZ, Biberfeld P., Larsson L., Beaver B., Wong-Staal F., and Gallo RC (1989). AIDS Kaposi's sarcoma derived cells express cytokines with autocrine and paracrine growth effects. Science243: 223-226.
39.
Salahuddin SZ , Nakamura S., Biberfeld P., Kaplan MH, Markham PD, Larsson L., and Gallo RC (1988). Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science242: 430-433.
40.
Kato S., Petruzzelli S., Bowman ED, Turtletaub KW, Blomeke B., Weston A., and Shields PG (1993). 7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay. Carcinogenesis14: 545-550.
41.
Nakachi K., Imai K., Hayashi S., Watanabe J., and Kawajiri K. (1991). Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 51: 5177-5180.
42.
Shields PG, Bowman ED, Harrington AM, Doan VT, and Weston A. (1993). Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 53: 3486-3492.
43.
Klein-Szanto AJP , Jizasa T., Momiki S., Garcia-Palazzo J., Caamano J., Metcalf R., Welsh J., and Harris CC (1992). A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA89: 6693-6697.
44.
Mace K., Gonzalez F., McConnell IR, Garner RC, Avanti O., Harris CC, and Pfeifer A. (1994). Activation of pro-mutagens in a human bronchial epithelial cell line stably expressing human CYP1A2. Mol. Carcinogen. (in press).
45.
Pfeifer AMA , Cole KE, Smoot DT, Weston A., Groopman JD, Shields PG, Vignaud J-M., Juillerat M., Lipsky MM, Trump BF, Lechner JF, and Harris CC (1993). Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc. Natl. Acad. Sci. USA90: 5123-5127.
46.
Pfeifer A., Mark GE, Malan-Shibley L., Graziano SL, Amstad P., and Harris CC (1989). Cooperation of c-ras-1 and c-myc protooncogenes in the neoplastic transformation of SV40 T-antigen immortalized human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA86: 10075-10079.
47.
Reddel RR, Ke Y., Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, and Harris CC (1988). Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48: 1904-1909.
48.
Haseman JK, Zeiger E., Shelby MD, Margolin BH, and Tennant RW (1990). Predicting rodent carcinogenicity from four in vitro genetic toxicity assays: An evaluation of 114 chemicals studied by the National Toxicology Program. J. Am. Stat. Assoc. 85: 964-971.
49.
Isfort RJ, Cody DB, Asquith TN, Ridder GM, Stuard SB, and LeBoeuf RA (1993). Induction of protein phosphorylation, protein synthesis, immediate early gene expression and cellular proliferation by intracellular pH modulation. Eur. J. Biochem. 213: 349-357.
50.
Isfort RJ, Cody DB, Doerson C., Kerckaert GA, and LeBoeuf RA (1994). Stage specific alterations in cellular differentiation, mitogenesis and cytoskeletal markers during Syrian hamster embryo cell multistep in vitro transformation. Int. J. Cancer (in press).
51.
LeBoeuf RA and Kerckaert GA, Poiley JA, and Raineri R. (1989). An interlaboratory comparison of enhanced morphological transformation of Syrian hamster embryo cells cultured under conditions of reduced bicarbonate concentration and pH. Mut. Res. 222: 205-218.
52.
Swierenga SH and Yamasaki H. (1992). Performance of tests for cell transformation and gap junction intercellular communication for detecting nongenotoxic carcinogenic activity. In: Mechanisms of Carcinogenesis in Risk Identification , H Vainio, PN Mcgee, DB McGregor, and AJ McMichael (eds.). International Agency for Research on Cancer, Lyon, pp. 165-193.
53.
Grilli M., Chiu JS, and Lenardo MJ (1993). NF-kB and Rel-Participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143: 1-62.
54.
Higgins KA, Perez JR, Coleman TA, Dorshkind K., McComas WA, Sarmiento UM, Rosen CA, and Narayanan R. (1993). Antisense inhibition of the p65 subunit of NF-kB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA90: 9901-9905.
55.
Kitajima I., Shinohara T., Bilakovics J., Brown DA, Xu X., and Nerenberg M. (1992). Ablation of transplanted HTLV-1 tax-transformed tumors in mice by antisense inhibition of NF-kB. Science258: 1792-1795.
56.
Narayanan R. , Higgins KA, Perez JR, Coleman TA, and Rosen CA (1993). Evidence for differential functions of the p50 and p65 subunits of NF-kB using a cell adhesion model . Mol. Cell. Biol. 13: 3802-3810.
57.
Perez JR, Li Y., Stein CA, Majumder S., van Oorschot A., and Narayanan R. (1994). Sequence independent induction of Sp-1 transcription factor by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA (in press).
58.
Simons M., Edelman ER, Dekeyser JL, Langer R., and Rosenberg RD (1992). Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (London)359: 67-70.
59.
Sokoloski JA , Sartorelli AC, Rosen CA, and Narayanan R. (1993). Antisense oligonucleotides to the p65 subunit of NF-kB block CD 11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood82: 625-632.
60.
Stein CA and Cheng YC (1993). Antisense oligonucleotides as therapeutic agents-Is the bullet really magical? Science261: 1004-1012.
61.
Cai DW, Mukhopadhyay T., Liu T., et al (1993). Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. Human Gene Ther. 4: 617-624.
62.
Casson AG, Mukhopadhyay T., Cleary KR, et al (1991). p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res. 51: 4495-4499.
63.
Fujiwara T., Grimm EA, Mukhopadhyay T., et al (1993). A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis . Cancer Res. 53: 4129-4133.
64.
Fujiwara T., Grimm EA, Mukhopadhyay T., et al (1994). Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 54: 2287-2291.
65.
Georges RN, Mukhopadhyay T., Zhang YJ, et al (1993). Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras contruct . Cancer Res. 53: 1743-1746.
66.
Zhang YJ, Mukhopadhyay T., Donehower LW, et al (1993). Retroviral vector-mediated transduction of k-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Human Gene Ther. 4: 451-460.
67.
Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl. J. Med. 330: 1029-1035.
68.
Blot WJ, Li J-Y., Taylor PR, Guo W., Dawsey S., Wang G-Q., Yang CS, Zheng S-F., Gail M., Li G-Y., Yu Y., Liu B-Q., Tangrea J., Sun Y-H., Liu F., Fraumeni FJ Jr, Zhang Y-H., and Li B. (1993). Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85: 1483-1492.
69.
Goodman GE, Metch BJ, and Omenn GS (1994). The effect of long-term beta-carotene and vitamin A administration on serum concentrations of alpha-tocopherol. Cancer Epidemiol. Biomarkers Prev.3 (in press).
70.
Hennekens CH , Buring JE, and Peto R. (1994). Antioxidant vitamins-Benefits not yet proved. New Engl. J. Med. 330: 1080-1081.
71.
Omenn GS, Goodman G., Thornquist M., Grizzle J., Rosenstock L., Barnhart S., Balmes J., Cherniack M., Cullen M., Glass A., Keogh J., Meyskens F. Jr, Valanis B., and Williams J. (1994). The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high-risk populations: Smokers and asbestos-exposed workers. Cancer Res. 54:2038s-2043s.
72.
Peto R., Doll R., Buckley JD, and Sporn MB (1981). Can dietary beta-carotene materially reduce human cancer rates? Nature (London)290: 201-208.